Neurava
Neurava develops an AI-enabled wearable monitoring platform for people with epilepsy. The platform combines wearable physiological sensors, mobile apps, cloud analytics and clinician-facing tools to detect convulsive seizures, monitor cardiorespiratory function, generate alerts to caregivers/EMS, and support clinical validation and regulatory submission.
Industries
Nr. of Employees
small (1-50)
Products
Wearable convulsive seizure sensor (arm-worn)
A wearable sensor designed to detect and record convulsive seizure activity and generate alerts based on detected events.
Wearable cardiorespiratory sensor (neck-worn)
A wearable sensor that captures cardiac, respiratory and oxygen saturation signals to detect seizure-induced cardiorespiratory dysfunctions.
Mobile monitoring application
Mobile application that receives wearable data, stores medication history and notes, displays reports, and issues alerts to caregivers.
Clinician portal
Physician-facing portal for retrospective review of monitored data and comprehensive insights on patient events.
Neurava wearable platform
An AI-powered wearable platform revolutionizing epilepsy care through advanced detection and real-time alerts enabling proactive prevention of nighttime SUDEP for safer and more restful nights.
A1
An AI-powered wearable platform designed to monitor seizures and cardiorespiratory dysfunctions to mitigate SUDEP risk and provide peace of mind to epilepsy patients and their families.
Wearable convulsive seizure sensor (arm-worn)
A wearable sensor designed to detect and record convulsive seizure activity and generate alerts based on detected events.
Wearable cardiorespiratory sensor (neck-worn)
A wearable sensor that captures cardiac, respiratory and oxygen saturation signals to detect seizure-induced cardiorespiratory dysfunctions.
Mobile monitoring application
Mobile application that receives wearable data, stores medication history and notes, displays reports, and issues alerts to caregivers.
Clinician portal
Physician-facing portal for retrospective review of monitored data and comprehensive insights on patient events.
Neurava wearable platform
An AI-powered wearable platform revolutionizing epilepsy care through advanced detection and real-time alerts enabling proactive prevention of nighttime SUDEP for safer and more restful nights.
A1
An AI-powered wearable platform designed to monitor seizures and cardiorespiratory dysfunctions to mitigate SUDEP risk and provide peace of mind to epilepsy patients and their families.
Services
Integrated service combining wearable sensors, mobile app, cloud analytics and clinician portal to monitor seizures and cardiorespiratory function and provide real-time alerts to caregivers.
Integrated service combining wearable sensors, mobile app, cloud analytics and clinician portal to monitor seizures and cardiorespiratory function and provide real-time alerts to caregivers.
Expertise Areas
- Seizure detection and at‑home monitoring
- Cardiorespiratory monitoring in epilepsy
- AI/ML for biomedical signal detection
- Wearable device hardware and sensor design
Key Technologies
- Wearable physiological sensors
- Electrocardiography and cardiac monitoring
- Respiratory signal monitoring
- Pulse oximetry (oxygen saturation monitoring)
News & Updates
Venture capital round led by Elevate Ventures with participation from Purdue Foundry, First Leaf Capital and others to support device development.
Award and finalist placement in the 2023 MedTech Innovator program.
Recognition for innovation in 2022 (regional award).
Board additions announced as part of company growth and governance updates.
A near-SUDEP case study published in Epileptic Disorders describing a captured seizure with seizure-induced cardiorespiratory collapse.
Recorded first convulsive seizure during usability testing.
Venture capital round led by Elevate Ventures with participation from Purdue Foundry, First Leaf Capital and others to support device development.
Award and finalist placement in the 2023 MedTech Innovator program.
Recognition for innovation in 2022 (regional award).
Board additions announced as part of company growth and governance updates.
A near-SUDEP case study published in Epileptic Disorders describing a captured seizure with seizure-induced cardiorespiratory collapse.
Recorded first convulsive seizure during usability testing.